Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Nature|March 23, 1995
DNA-bend modulation in a repressor-to-activator switching mechanismA Z Ansari, J E Bradner, T V O'HalloranCancer Research|April 10, 1999
Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcomaP P Lin, R I Brody, A C Hamelin, et al.Oncogene|September 5, 2012
C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitorsL Barroilhet, J Yang, K Hasselblatt, et al.Cancer Research|October 17, 2014
Syntheses and discovery of a novel class of cinnamic hydroxamates as histone deacetylase inhibitors by multimodality molecular imaging in living subjectsC T Chan, J Qi, W Smith, et al.Leukemia|June 10, 2015
Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemiaG Wedeh, S Cerny-Reiterer, G Eisenwort, et al.Oncogene|May 12, 2015
The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft modelsP L Garcia, A L Miller, K M Kreitzburg, et al.Leukemia|February 21, 2014
Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemiaC Reynolds, J E Roderick, J L LaBelle, et al.Pageof 1